The article summarizes domestic and international studies on the development and clinical investigation of valproates including multiple studies of a research team directed by the author. Valproate targets are considered in biological and clinical aspects. A spectrum of action and advantages of the brand drug (depakine) compared to generics and other antiepileptic drugs are discussed. A number of recommendations for practitioners about using valproates are proposed.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.17116/jnevro2017117111129-134 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!